Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Impact of Continuous Glucose Monitoring on Maternal and Infant's Outcomes in Gestational Diabetes

NCT: NCT06436326 · RECRUITING

NCT IDNCT06436326
StatusRECRUITING
Start Date2024-08-22
Completion2027-12-31
SponsorNational Taiwan University Hospital (OTHER)
First posted
Last updated

Brief Summary

This study will discuss the impact of continuous glucose monitoring on maternal and infant's outcomes in gestational diabetes mellitus, and test the moderating effect of socioeconomic and cultural factors (dietary habits, socioeconomic status and income).

Frequently Asked Questions

What is The Impact of Continuous Glucose Monitoring on Maternal and Infant's Outcomes in Gestational Diabetes?

The Impact of Continuous Glucose Monitoring on Maternal and Infant's Outcomes in Gestational Diabetes is a clinical trial registered under NCT06436326. Current status: RECRUITING.

What is the status of NCT06436326?

The current status of NCT06436326 (The Impact of Continuous Glucose Monitoring on Maternal and Infant's Outcomes in Gestational Diabetes) is: RECRUITING.

When did The Impact of Continuous Glucose Monitoring on Maternal and Infant's Outcomes in Gestational Diabetes start?

The Impact of Continuous Glucose Monitoring on Maternal and Infant's Outcomes in Gestational Diabetes started on 2024-08-22.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑